Latest Gene expression profiling Stories
LC Sciences, a life sciences company leading the development of innovative microRNA (miRNA) analysis and discovery technologies, announced today the publication of over 250 peer-reviewed studies using the companyâ€™s microarray service for analyzing miRNA expression profiles.
NEW YORK, May 26, 2011 /PRNewswire/ -- Signal Genetics, the parent company of Myeloma Health LLC and Respira Health LLC, a privately held predictive genetic testing company focused on oncology, announced today a new agreement under which NeoGenomics Laboratories will offer Signal Genetics' new gene expression profile test for Multiple Myeloma (MyPRS(TM)) to pathologists and hospital-based hematologists/oncologists nationwide. Myeloma Prognostic Risk Signature(TM) (MyPRS) offers the most...
FREMONT, Calif., May 17, 2011 /PRNewswire/ -- WaferGen Biosystems, Inc.
Over the past decades, researchers seeking to understand molecular mechanisms underlying various diseases, notably cancer, have taken advantage of DNA microarrays to interrogate tissues specimen of patients for the expression status of thousands of genes at once.
FREMONT, Calif., March 29, 2011 /PRNewswire/ -- WaferGen Biosystems, Inc.
FREMONT, Calif. and SAN CARLOS, Calif., March 21, 2011 /PRNewswire/ -- WaferGen Biosystems, Inc.
BELMONT, Calif., March 16, 2011 /PRNewswire/ -- Phalanx Biotech Group, a global provider of genomic analysis services, announces its newest expression microarray - the Rat Whole Genome OneArrayÂ®.
Biliary atresia (BA) is an inflammatory obliterative cholangiopathy with unknown etiology, leading to progressive fibrosis and cirrhosis.
Thereâ€™s more than one way to silence gene activity, according to a Michigan State University researcher.
REDWOOD CITY, Calif., Feb. 3, 2011 /PRNewswire/ -- Genomic Health, Inc.
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.